RE: Huge upside29 Jan 2026 11:00
Mole/Scc
The Company has recently announced it is working with its partner, Thermo Fisher Scentific, to support its revenue scale-up and expansion strategy for its lead product CARDIO inCode-Score across Europe, the UK, and the United States which will assist the Company to transitioning towards break-even over the medium term.
CVD is the leading cause of death worldwide, responsible for over 17.9 million deaths annually, which equates to approximately 31% of all global deaths (World Health Organisation). With the global annual cost of CVD projected to surpass $1.04 trillion